William Daly, Chief Business Officer
William Daly joined Akebia as Senior Vice President, Business Development in 2012 and was promoted to Chief Business Officer in 2013. Mr. Daly also currently serves as Chief Business Officer of Aerpio Therapeutics, Inc. Prior to joining Akebia, Mr. Daly served as Senior Vice President, Business Development at Halozyme Therapeutics, a biopharmaceutical company, from 2009 to 2012, where he was the head of business development and alliance management. From 2007 to 2009, Mr. Daly was the Senior Vice President of Business Development at Cougar Biotechnology, a biopharmaceutical company, and then, after the acquisition of Cougar Biotechnology by Johnson & Johnson, co-led the integration of Cougar and Johnson & Johnson and was site head for the Los Angeles facility. Prior to joining Cougar, Mr. Daly held a number of business development and senior executive positions at Allergan, Chiron and Novartis as well as at a number of start-up biotechnology companies. Before moving into industry, Mr. Daly was an investment banker focusing primarily on pharmaceutical and biotechnology companies for nine years, most recently served as a Managing Director for Prudential Vector Healthcare Group. Prior to becoming an investment banker, he practiced corporate and securities law for ten years. Mr. Daly holds an A.B. in biochemistry from the University of California at Berkeley and a J.D. and M.B.A. from the University of California at Los Angeles.